Its murine parent monoclonal antibody 9E4 can ameliorate α-synuclein neuropathology and improve motor and cognitive deficits, as well as protecting against neurodegeneration in α-synuclein transgenic mouse models of PD [61]. Here, SNCA is linked to Parkinson disease.